The nigrostriatal dopamine system: a neglected target for 5-HT2C receptors.

[1]  E. Esposito,et al.  Role of 5-HT(2C) receptors in the control of central dopamine function. , 2001, Trends in pharmacological sciences.

[2]  M. Chesselet,et al.  Nigrostriatal Lesions Alter Oral Dyskinesia and c-Fos Expression Induced by the Serotonin Agonist 1-(m-Chlorophenyl)piperazine in Adult Rats , 2000, The Journal of Neuroscience.

[3]  M. Millan,et al.  Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat , 2000, Synapse.

[4]  U. Spampinato,et al.  The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT2A and 5-HT2C receptor subtypes and significance of the haloperidol dose used , 2000, Neuropharmacology.

[5]  M. Millan,et al.  Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2‐adrenergic and serotonin2C receptors: a comparison with citalopram , 2000, The European journal of neuroscience.

[6]  U. Spampinato,et al.  Role of Striatal Serotonin2A and Serotonin2C Receptor Subtypes in the Control of In Vivo Dopamine Outflow in the Rat Striatum , 2000, Journal of neurochemistry.

[7]  P. De Deurwaerdère,et al.  Role of Serotonin2A and Serotonin2B/2C Receptor Subtypes in the Control of Accumbal and Striatal Dopamine Release Elicited In Vivo by Dorsal Raphe Nucleus Electrical Stimulation , 1999, Journal of neurochemistry.

[8]  E. Esposito,et al.  SB 242 084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system , 1999, Neuropharmacology.

[9]  U. Spampinato,et al.  Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study , 1999, Neuroscience.

[10]  K. Cunningham,et al.  Effects of the 5-HT2C/2B Antagonist SB 206553 on Hyperactivity Induced by Cocaine , 1999, Neuropsychopharmacology.

[11]  T. Blackburn,et al.  Attenuation of haloperidol‐induced catalepsy by a 5‐HT2C receptor antagonist , 1999, British journal of pharmacology.

[12]  J. Brotchie,et al.  Behavioral Effects of 5-HT2CReceptor Antagonism in the Substantia Nigra Zona Reticulata of the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease , 1998, Experimental Neurology.

[13]  L. Descarries,et al.  Serotonin Neural Adaptations to Ontogenetic Loss of Dopamine Neurons in Rat Brain , 1998, Journal of neurochemistry.

[14]  H. Meltzer,et al.  Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens , 1998, Brain Research.